Novo Nordisk launched Wegovy in India in June 2025, shortly after global rival Eli Lilly rolled out its patented brand ...

A steep decline in Ozempic maker Novo Nordisk’s share price has sent consumer confidence ... has suffered amid worries over ...

Telehealth company Ro has enlisted former tennis player Serena Williams as a celebrity patient ambassador for its weight-loss treatments, it said on Thursday. Read more at straitstimes.com. Read more ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Serena Williams has joined telehealth company Ro as a celebrity ambassador for their weight-loss treatments. Williams will star in ads for GLP-1 medications and share her health journey post-pregnancy ...

The United States and European Union on Thursday released new details of their trade framework, providing clarity on tariffs for sectors including pharmaceuticals, semiconductors, and autos after ...

Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the ...

Demand for Novo Nordisk A/S’s weight-loss blockbuster Wegovy is getting a boost in the UK from an unexpected corner: ...

In people with recently diagnosed type 2 diabetes and no prior cardiovascular disease, self-reported physical activity ...

COPENHAGEN (Reuters) -As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing capacity and sales outreach with a hiring spree that ...

Diabetes and weight loss juggernauts from Eli Lilly and Novo Nordisk climbed again with double-digit growth. But drugmakers ...

As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing capacity and sales outreach with a hiring spree that almost doubled staff ...